Medicine and Dentistry
COVID-19
100%
Hypoxia
72%
Heart Right Ventricle Failure
71%
Pulmonary Hypertension
57%
Hydrocortisone
50%
Empagliflozin
50%
Monocrotaline Pyrrole
50%
Parosmia
50%
Placebo
50%
Semaxanib
50%
Pneumonectomy
50%
Right Ventricular Hypertrophy
50%
Right Ventricular Function
32%
Systolic Blood Pressure
26%
Echocardiography
23%
Heart Output
22%
Clinical Trial
16%
Intubation
16%
Pulmonary Vasculature
13%
Olfaction
12%
Prognostic Factor
12%
Physical Activity
12%
Quality of Life
12%
Body Mass Index
12%
Hemodynamic
11%
Vascular Remodeling
11%
Ventricular Dysfunction
10%
Adverse Event
8%
Artificial Respiration
8%
Cardiovascular Disease
8%
Silo-Filler's Disease
8%
Cardiac Catheterization
8%
Ligation
8%
Reproductive Medicine
8%
Heart Right Ventricle Pressure
8%
Phenotype
8%
Diuresis
7%
Cardiac Magnetic Resonance Imaging
7%
Systolic Function
7%
Blood Glucose
7%
Heart Right Ventricle Function
7%
Diastolic Function
7%
Erythromycin Ethylsuccinate
7%
Sodium Glucose Cotransporter 2 Inhibitor
7%
Hematocrit
7%
Water Intake
7%
Lung Surgery
7%
Left Ventricle
7%
Monocrotaline
5%
Persistent Fetal Circulation
5%
Pharmacology, Toxicology and Pharmaceutical Science
Hypoxia
72%
Heart Right Ventricle Failure
71%
Pulmonary Hypertension
69%
Semaxanib
50%
Monocrotaline Pyrrole
50%
Placebo
50%
Hydrocortisone
50%
Empagliflozin
50%
Mouse
50%
Dopamine Beta Monooxygenase
50%
Noradrenalin
25%
Heart Ventricle Remodeling
25%
Clinical Trial
20%
Wistar Rat
19%
Ivabradine
12%
Vascular Remodeling
11%
Adverse Event
10%
Diuretic Agent
7%
Preclinical Study
7%
Clinical Study
7%
Erythromycin Ethylsuccinate
7%
Sodium Glucose Cotransporter 2 Inhibitor
7%
Persistent Pulmonary Hypertension
5%
Monocrotaline
5%
Neointima
5%
Vasculotropin
5%
C57BL 6 Mouse
5%
Inflammation
5%
Mouse Model
5%